Glutamate acting on N-methyl-d-aspartate (NMDA) receptors induces neuronal injury following stroke, through activation of poly(ADPribose) polymerase-1 (PARP-1) and generation of the death molecule poly(ADP-ribose) (PAR) polymer. Here we identify Iduna, a previously undescribed NMDA receptor-induced survival protein that is neuroprotective against glutamate NMDA receptor-mediated excitotoxicity both in vitro and in vivo and against stroke through interfering with PAR polymer-induced cell death (parthanatos). Iduna's protective effects are independent and downstream of PARP-1 activity. Iduna is a PAR polymer-binding protein, and mutation at the PAR polymer binding site abolishes the PAR binding activity of Iduna and attenuates its protective actions. Iduna is protective in vivo against NMDA-induced excitotoxicity and middle cerebral artery occlusion-induced stroke in mice. To our knowledge, these results define Iduna as the first known endogenous inhibitor of parthanatos. Interfering with PAR polymer signaling could be a new therapeutic strategy for the treatment of neurologic disorders.
Glutamate is the major excitatory neurotransmitter regulating normal physiologic activity in the brain. Excessive glutamate release leads to excitotoxicity, which has a prominent role in many disorders of the nervous system, including trauma and ischemic brain injury 1 , and dysfunctional glutamate neurotransmission contributes to seizures and neurodegenerative disorders 2 . Glutamate excitotoxicity is mediated largely through influx of calcium through the NMDA receptor, leading to activation of PARP-1 and generation of PAR polymer, a newly described death signal that kills cells through apoptosis inducing factor (AIF). Genetic deletion or drug inhibition of PARP-1 result in profound neuroprotection. This form of cell death has recently been designated parthanatos, to distinguish it from apoptosis, autophagy and necrosis 3, 4 . Parthanatos is implicated in models of diabetes, inflammation, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity, myocardial infarction and cerebral ischemia 5 .
Under physiologic conditions, normal bursts of excitatory activity result in synaptic transmission and the expression of molecular substrates of long-term plasticity, growth and survival 6 . The activation of NMDA receptors in glutamatergic neurons is prominent in inducing these long-lasting synaptic changes through multiple downstream signaling molecules and changes in gene expression [7] [8] [9] [10] . NMDA receptor stimulation may also have a role for long-term changes that lead to neuronal survival 11 . We report here the identification and characterization of Iduna (encoded by Rnf146), an NMDA-induced cell survival molecule that protects against NMDA excitotoxicity and stroke through binding PAR polymer and blocking parthanatos.
RESULTS

Expression and induction of Iduna
In a previous study, we identified NMDA-induced plasticity late response genes from cortical neurons by differential analysis of primary cDNA library expression 12 . Of the many genes identified, here we characterize PLING932 (ref. 12) , currently annotated as Rnf146, which encodes a protein of 359 amino acids with a predicted molecular weight of 39.8 kDa, named Iduna for the Norse goddess of protection and eternal youth (Fig. 1a) . There is a high degree of homology between the human, rat and mouse Iduna proteins. Two regions are also evolutionary conserved in zebrafish and nematodes, those associated with the RING finger domain (amino acids ) and the WWE domain (amino acids 91-167) (Fig. 1a) .
By northern blot analysis, Iduna is basally expressed at relatively high levels in mouse brain, but it is also present in spleen, heart, kidney, testis and liver (Fig. 1b) , with two Iduna transcripts in the testis. A polyclonal antibody to Iduna, which recognizes a single 40-kDa protein on immunoblotting ( Supplementary Fig. 1a,b) , reveals variable expression of Iduna protein in various brain regions, suggesting a regional diversity in Iduna activity (Fig. 1c) .
Iduna mRNA expression in mouse cortical neuronal cultures, as assessed by real-time PCR, increases after treatment with 50 µM NMDA (Fig. 1d) , consistent with our microarray screen 12 . Iduna protein expression also increases after treatment with 50 µM NMDA (Fig. 1e) . Both Iduna mRNA and protein follow a similar pattern of expression, peaking at 36 h after NMDA-mediated stimulation (Fig. 1d,e) . A toxic dose of NMDA (500 µM for 5 min) fails to induce Iduna expression (Fig. 1f) . Sublethal exposure to oxygen-glucose deprivation (OGD), which induces tolerance to subsequent lethal insults 13 , also induces Iduna protein expression (Fig. 1g) . A 5-min bilateral common carotid artery occlusion (BCCAO) in mice results in resistance to subsequent ischemic injury 14 and induces Iduna mRNA and protein expression (Fig. 1h,i) .
Iduna is neuroprotective
Iduna expression is elevated after stressful events, resulting in enhanced neuroprotection, and raises the possibility that Iduna may mediate the protective response. Lentiviral transduction of EGFP-tagged Iduna (GFP-Iduna) in mouse cortical neurons protected against NMDAinduced cell death to a similar degree as the protection afforded by 50 µM NMDA (Fig. 2a) . To determine whether Iduna mediates NMDAinduced neuronal survival, we assessed knockdown of Iduna induction by lentivirally expressed shRNA targeting Iduna (Fig. 2b,c) . shRNA targeting Iduna (shRNA Iduna) abolished the NMDA-induced protection (Fig. 2a) . To control for nonspecific effects of shRNA, we used lentiviral shRNA DsRed, which engages the RISC complex but should have no effect on cell signaling events, and it has no significant effect on NMDA-induced upregulation of Iduna (Fig. 2b,c) , NMDA-induced cell survival (Fig. 2a) or cell death (Fig. 2d) . Knockdown of Iduna had no effect on cell viability after a toxic 500-µM dose of NMDA (Fig. 2d) . The Iduna-specific antibody recognizes both human and mouse Iduna (Supplementary Fig. 1b) . Within the DNA sequence of Iduna, between base pairs 556 and 576 there are five differences between the mouse and human sequences, which is sufficient to render human Iduna resistant to knockdown with the shRNA targeted toward mouse Iduna, thus providing a rescue control for possible off-target effects of shRNA Iduna (Fig. 2e,f) . Overexpression of human Iduna in mouse cortical neuronal cultures was protective against excitotoxic NMDA treatment in the setting of loss of mouse Iduna expression from shRNA Iduna knockdown (Fig. 2g) , confirming the specificity of the shRNA-mediated knockdown of mouse Iduna. These results taken together indicate that Iduna is an NMDA-induced protective protein. 
Iduna is a PAR binding protein
Iduna contains a RING finger domain and a WWE domain and within the WWE domain there is a putative PAR binding motif (Fig. 1a) .
Given that PAR is a newly discovered death signal 15 , we wanted to determine the ability of Iduna to bind PAR polymer. Dot blots of immunoprecipitated GFP-Iduna incubated with biotin-labeled PAR polymer and probed with a biotin-specific antibody showed that GFP-Iduna binds PAR polymer, whereas GFP alone did not (Fig. 3a) . PAR polymer overlay assays with immunoprecipitated GFP-Iduna revealed that PAR polymer specifically bound GFP-Iduna but not GFP (Fig. 3b) . In addition, poly(ADP-ribosyl)ated proteins immunoprecipitated with GFP-Iduna (Fig. 3b) . In a PAR polymer binding assay, GFP-Iduna or histone 3 (H3) (a positive control) bound radiolabeled free PAR polymer, but GFP did not (Supplementary Fig. 2a ). Iduna bound a range of PAR polymers of varying length, as determined by phosphorimager detection of radiolabeled PAR polymer bound to GFP-Iduna after separation by Tris-borate-EDTA PAGE (Fig. 3c) . In primary neuronal cultures treated with 50 µM NMDA, we found that that Iduna immunoprecipitates with PAR polymer, as determined by immunoblot analysis (Fig. 3d) . Because in resting neurons Iduna is expressed at low levels, and there is relatively little PAR polymer, we found no detectable interaction between Iduna and PAR polymer under resting conditions (Fig. 3d) . Taken together, these results indicate that Iduna is a PAR polymer-binding protein.
PAR binding is specified by a sequence of approximately 20 amino acids containing N-terminal basic amino acids and a C-terminal region containing alternating hydrophobic and basic amino acids ( Fig. 3e) 16, 17 . Iduna contains a predicted PAR polymer-binding sequence within amino acids 144-167 of the WWE domain ( Fig. 1a and Fig. 3e) . We defined the PAR-binding domain by comparing to the consensus sequence for PAR binding and the known PAR binding domain of H3 (Fig. 3e) . We transfected HEK293 cells with GFP, GFPIduna lacking the WWE domain (GFP-Iduna∆WWE), GFP-Iduna lacking the RING finger domain (GFP-Iduna∆RF) and full-length GFP-Iduna, followed by immunoprecipitation with a GFP-specific antibody. A PAR polymer overlay assay of the immunoprecipitate showed that PAR polymer binds GFP-Iduna∆RF and full-length GFPIduna and immunoprecipitates PAR-binding proteins, but it failed to bind GFP and GFP-Iduna∆WWE (Fig. 3f) . Only GFP-Iduna-∆RF and full-length GFP-Iduna could immunoprecipitate PAR-binding proteins (Fig. 3f) . We mutated the key amino acids in the PAR-binding domain, Tyr156 and Arg157, to Ala156 and Ala157 in full-length Iduna (Iduna-YRAA). A PAR polymer overlay assay revealed that PAR polymer binds GFP-Iduna and immunoprecipitates PAR-binding proteins but fails to bind GFP-Iduna-YRAA or immunoprecipitate PAR-binding proteins (Fig. 3g) . We obtained similar results with a biotin-tagged PAR polymer followed by detection with an antibody to biotin (Fig. 3g) . A synthesized peptide fragment of the predicted PAR polymer binding sequence in Iduna, between of amino acids 144 and 167 of the WWE domain (Iduna 144-167), bound PAR polymer in a manner comparable to full-length Iduna (Supplementary Fig. 2b ). However, when the peptide fragment was synthesized with Arg156 and Arg157 to disrupt the PAR binding site (Iduna 144-167 YRAA), it failed to bind PAR polymer (Supplementary Fig. 2b ). Histone H3 is a known PAR-binding protein, and we used it as a positive control for the PAR overlay assay. Full-length GST-Iduna bound PAR polymer, whereas GST alone or GST-Iduna-YRAA failed to bind PAR polymer in the PAR polymer overlay assay (Supplementary Fig. 2b ). We developed an assay based on electrophoretic mobility shift (EMSA) for PAR binding to monitor PAR polymer binding to Iduna. Iduna retarded the mobility shift of PAR polymer, whereas GST or GSTIduna-YRAA had no effect of PAR polymer mobility shift. H3 also retarded the PAR polymer mobility shift (Supplementary Fig. 2c) .
We determined the affinity of Iduna and Iduna-YRAA for PAR by a competition assay with increasing concentrations of unlabeled PAR polymer against 2.5 nM [ 32 P]-labeled PAR polymer (mean size of 40 ADP-ribose units) (Fig. 3h) . From the competitive binding curve, the half-maximal effective concentration of wild-type Iduna for PAR polymer was 14.5 ± 0.13 nM (P > 0.001), calculated as a function of PAR polymer concentration, and the maximum binding capacity (B max ) was 3.04 ± 0.16 pmol. The PAR polymer synthesized by in vitro automodification of PARP-1 has a mean length of 40 ADPribose residues 18 , and, accordingly, the concentration of PAR is given as a function of polymer molecules, with a mean size of 40 ADPribose units. These concentrations of PAR polymers are within the range of polymer concentrations found in intact cells during NMDA excitotoxicity and N-methyl-N-nitro-N-nitrosoguanidine (MNNG) toxicity 15, 19 . PAR polymer failed to bind Iduna-YRAA (Fig. 3h) . The homologous competitive binding curve for wild-type Iduna, analyzed by the Cheng-Prusoff equation, provided a dissociation constant (K d ) for wild-type Iduna of 12.0 nM. This observed K d is ten times less than the PAR polymer concentration found after NMDA-induced excitotoxicity in cortical neurons 15 . These results taken together indicate that Iduna is a high-affinity and saturable PAR polymer binding protein through its WWE domain and that the basic and hydrophobic amino acids Tyr156 and Arg157 are essential for PAR polymer binding.
The neuroprotective actions of Iduna are PAR dependent
Because PARP-1 activation has a prominent role in NMDA-induced excitotoxicity 5, 20 , we tested whether PARP-1 activity is directly affected by Iduna. We assessed PARP-1 activity by incorporation of biotinylated PAR onto histone proteins. The PARP-1 inhibitor 3-aminobenzamide inhibited PARP-1 activity, but Iduna had no effect (Fig. 3i) . Iduna also failed to inhibit PARP-1 catalytic activity, as assessed by 32 P-NAD incorporation into radiolabeled PAR polymer (Fig. 3j) . Thus, Iduna does not inhibit PARP-1 catalytic activity and is a PAR-binding protein that acts downstream of PARP-1 activation.
To ascertain whether the binding of Iduna to PAR polymer affects the neuroprotective actions of Iduna against NMDA excitotoxicity and parthanatos, we transiently transfected mouse neuronal cultures with GFP-tagged-Iduna and GFP-tagged Iduna mutants (Fig. 4a) . Both GFP-Iduna and GFP-Iduna∆RF, which contain the PARbinding domain, prevented NMDA-mediated excitotoxicity, whereas Anti-GFP Anti-GFP Anti-PAR GFP-Iduna∆WWE and GFP-Iduna-YRAA failed to protect against NMDA-mediated excitotoxicity (Fig. 4a) . As transient transfections are effective in only a small population of neurons, we used lentiviruses to express GFP, GFP-Iduna or GFP-Iduna-YRAA in neuronal culture with an efficiency greater than 95% ( Fig. 4b and Supplementary  Fig. 3 ). Immunoblot analysis reveals equivalent protein expression of GFP-Iduna and GFP-Iduna-YRAA ( Fig. 4c) with primarily cytoplasmic localizations similar to endogenous Iduna, as determined by confocal microscopy and subcellular fractionation ( Fig. 4b and Supplementary Fig. 4) . A small amount of endogenous Iduna and lentivirally expressed GFP-Iduna and GFP-Iduna-YRAA seemed to translocate to the nucleus after an excitotoxic dose of NMDA (500 µM) (Supplementary Fig. 4) . Thus, we could not exclude the possibility of Iduna's translocation to the nucleus contributing to its protective effect. However, given that Iduna is a primarily a cytosolic protein, and the protective actions of Iduna do not require an interaction with PARP-1 (Fig. 3i,j) , it is likely the protective effects occur in the cytoplasm. As PAR exits the nucleus to mediate its toxicity 15, 21 , the actions of Iduna in the cytoplasm may be important for the regulation of cell viability. Overexpression of GFP-Iduna protected neuronal cultures against NMDA excitotoxicity, whereas GFP-Iduna-YRAA or GFP failed to provide neuroprotection (Figs. 2a and 4d) . We obtained similar results using Alamar Blue reduction to assess cell viability 22 ( Fig. 4e) . Iduna overexpression also protected neuronal cultures against a lower excitotoxic dose of NMDA (100 µM for 5 min) (percentage cell death: nontranfected control 44.2 ± 3.2, Iduna 23.0 ± 1.8, mean ± s.e.m., *P < 0.05). To determine whether Iduna protects against other forms of parthanatos, we exposed cortical neurons to the DNA alkylating agent and PARP-1 activator MNNG under conditions where MNNG toxicity is PARP-1 dependent (MNNG, 50 µM for 15 min). Iduna protected neuronal cultures against MNNG-induced cell death, whereas Iduna-YRAA or GFP failed to provide any protection (Fig. 4f) . Expression of GFP-Iduna or GFP-Iduna-YRAA had no effect against apoptotic cell death in neuronal cultures treated with staurosporine (500 nM) or camptothecin (20 µM). Both staurosporine and camptothecin induced caspase-dependent cell death, as the pancaspase inhibitor z-VAD fmk inhibited cell death in neuronal cultures (Supplementary Fig. 5 ). In neuronal cultures, 100 µM H 2 O 2 triggers parthanatos, which is prevented by the PARP inhibitor DPQ, but 500 µM H 2 O 2 activates different cell death events, and DPQ is not protective. Consistent with its role in protecting against parthanatos, Iduna protected only against 100 µM H 2 O 2 ( Supplementary Fig. 6 ).
As calcium dysregulation is an early event in NMDA neurotoxicity, we wanted to determine the effect of Iduna on calcium mobilization. Expression of Iduna, Iduna-YRAA or GFP did not interfere with NMDA-induced intracellular calcium influx determined in mouse neuronal cultures loaded with fluo-5F and quantified by live-cell calcium imaging (Fig. 5a,b and Supplementary Fig. 7 ). In addition, Iduna overexpression did not interfere with mitochondrial calcium uptake (Fig. 5c) . These results taken together indicate that the neuroprotection elicited by Iduna against NMDA-mediated excitotoxicity is not due to interference with NMDA-induced elevations of calcium.
Iduna prevents the translocation of AIF Parthanatos involves the translocation of AIF from the mitochondria to the nucleus following NMDA excitotoxicity 5, 15, 19, 21 . We monitored AIF translocation after excitotoxic NMDA treatment by immunohistochemistry and confocal microscopy ( Fig. 5d) and by immunoblot analysis of nuclear and mitochondrial subcellular fractions (Fig. 5e) . AIF translocated to the nucleus in neurons expressing GFP or Iduna-YRAA following NMDA-induced excitotoxicity, whereas expression of Iduna reduced the translocation of AIF (Fig. 5f ) comparable to the degree of neuroprotection afforded by Iduna overexpression. During parthanatos, cytochrome c is released from mitochondria long after AIF translocates to the nucleus, after 1-2 h 19, 20 . Consistent with the protective effects of Iduna against parthanatos, we observe a decrease in cytochrome c translocation from mitochondria to the cytoplasm with overexpression of Iduna compared to Iduna-YRAA or GFP (Supplementary Fig. 8 ).
Mitochondrial membrane potential (∆ψ m ) reduction accompanies the translocation of AIF during NMDA excitotoxicity 20 . Overexpression of Iduna prevented NMDA-induced loss of ∆ψ m , as monitored by tetramethylrhodamine methyl ester (TMRM) fluorescence, compared to overexpression of Iduna-YRAA or GFP (Fig. 5g,h and Supplementary  Fig. 9 ), similar to the reduction in AIF nuclear translocation and cell death. These results indicate that Iduna prevents AIF translocation and reductions in ∆ψ m in a PAR binding-dependent manner.
Iduna is protective in vivo
To determine whether Iduna is protective in vivo, we generated transgenic mice overexpressing Iduna by knocking the gene encoding Iduna into the ROSA26 genomic locus, resulting in a fourfold expression over wild-type littermate mice (Fig. 6a-c) . The volume of NMDA-induced lesions were reduced by approximately 80% in the Iduna-transgenic mice compared to wild-type littermate control mice after an intrastriatal injection of NMDA (20 nmol) (Fig. 6d,e) .
To explore whether Iduna provides protection in vivo in a PARdependent manner, we injected mice stereotactically with lentiviruses encoding GFP-Iduna, GFP-Iduna-YRAA or GFP, followed by intrastriatal injection of NMDA (20 nmol) 5 d after viral injection. Cell survival was assessed by stereologic cell counting of GFP-positive neurons in mouse brain sections 48 h after the NMDA injection. In GFP-injected mice, NMDA injection led to a 90% loss of GFP-positive cells, whereas GFP-Iduna protected approximately 51% of the neurons against NMDA lesions (Fig. 6f) , similar to the protection we observed in vitro and in the Iduna-transgenic mice. GFP-Iduna-YRAA was not able to protect against NMDA excitotoxic injections ( Fig. 6f and  Supplementary Fig. 10 ). These data indicate that either constitutive or acute overexpression of Iduna is neuroprotective in vivo. Moreover, Iduna-mediated protection is dependent on PAR binding.
We determined neuroprotection against ischemic injury by subjecting wild-type littermates and Iduna-transgenic mice to transient occlusion of the middle cerebral artery. Over the 60-min period of occlusion, cortical perfusion monitored by laser-Doppler flowmetry was reduced equivalently in wild-type mice (10 ± 1% of baseline; ± s.e.m.) and Iduna-transgenic mice (12 ± 2%). The reduction was stable throughout the occlusion period and recovered to preischemic levels immediately upon removal of the filament in both groups (Fig. 6g) . Despite the similar intensity of the ischemic insult, infarct volume was reduced by 50% in Iduna-transgenic mice compared to their wild-type counterparts (Fig. 6h) . Moreover, the reduction in infarct size was not skewed to a particular coronal level (Fig. 6h) . Likewise, Iduna-transgenic mice showed improved neurological function after stroke. There were no baseline neurobehavioral differences in Iduna-transgenic and wild-type mice ( Supplementary  Fig. 11 ). Thus, Iduna overexpression protects against stroke induced neuronal injury.
DISCUSSION
We report the discovery of Iduna, a neuroprotective protein. Iduna protects against parthanatos, NMDA receptor-mediated glutamate excitotoxicity both in vitro and in vivo and ischemia due to middle cerebral artery occlusion. Iduna is normally expressed at low levels in the nervous system, but expression substantially increases after a low dose of NMDA, a sublethal exposure to OGD or a brief exposure to BCCAO, all of which induce neuroprotection 13, 14, 23 . Thus, Iduna plays a part in the protective response to NMDA and ischemia and in the subsequent development of tolerance to lethal insults. Consistent with this notion is our observation that shRNA-mediated knockdown of Iduna completely abolishes the protective effects of the neuroprotective dose of NMDA and that overexpression of Iduna is neuroprotective. The PAR polymer-binding activity of Iduna is essential for its neuroprotective function. Emerging evidence reveals that PAR polymer binds a variety of proteins in a saturable and highly specific manner [24] [25] [26] [27] [28] [29] . A recent unbiased proteomic screen for PAR-binding proteins identified a number of proteins, including AIF 16 . Mutation of the PAR-binding domain in AIF prevents the translocation of AIF from the mitochondria and promotes cell survival 4 . That Iduna blocks the translocation of AIF from the mitochondria to the nucleus is consistent with these observations. How PAR binding to Iduna regulates subsequent PAR-dependent signaling events, including AIF release, is not yet known. However, the ability to interfere with PAR-dependent signaling events positions Iduna as an endogenous functional antagonist of PAR polymer death signaling. Induction of neuroprotective proteins, including Iduna by NMDA, OGD or ischemia, is probably a result of multiple different signaling events. Low concentrations of NMDA (50 µM) or nonlethal OGD induces long-lasting neuroprotection that seems similar to that induced by disinhibition of GABAergic neurons by bicuculline administration 13, [30] [31] [32] [33] , to activate calcium-, nitric oxide-and MAP kinase kinase-dependent pathways 13, 34 , as well as cAMP response element-binding protein-dependent signaling [30] [31] [32] . Different induction paradigms probably activate divergent cell survival pathways by preferential activation of synaptic and extrasynaptic receptors 11, [35] [36] [37] . Research into neuroprotective mechanisms has at its heart the goal of developing new therapeutic strategies to treat patients 23 . Although induction strategies might have limited use for acute injuries such as stroke or trauma, they may be useful in treating patients undergoing cardiac bypass surgery, neurosurgery or other surgical cohorts where ischemia is a risk. Patients with subarachnoid hemorrhage or transient ischemic attacks, soldiers at risk for blast injury or perhaps even patients suffering from chronic neurodegenerative diseases could also benefit from enhancing neuronal survival. Notably, a cohort of diverse signaling events has been linked to neuroprotection 23 , which suggests that in the brain there is a complex epistasis where multiple parallel pathways are capable of producing a neuroprotective phenotype. As technology for genome-wide detection of transcriptional targets and high-throughput proteomics becomes more robust, researchers will be in a better position to address this key question and understand how these divergent signals integrate to regulate neuronal survival. In summary, Iduna represents a newly identified protein that confers protection against parthanatos in a manner analogous to that in which Bcl-2 and inhibitors of apoptosis prevent apoptosis. The mechanism by which Iduna protects against parthanatos unveils a previously unrecognized endogenous protective process that involves interference with PAR polymer-mediated toxicity downstream of PARP-1 activation. Owing to the role of PARP-1 activation in many neurologic diseases and in ischemia reperfusion injury in organs 5, 8, 38 , therapies aimed at blocking PAR polymer-induced cell death by activating Iduna or mimicking the effects of Iduna could represent new therapeutic targets to prevent the toxic effects of PARP-1 activation and cell death.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
